Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sanofi SA (NYSE:SNY)

38.79
Delayed Data
As of Aug 26
 +0.34 / +0.88%
Today’s Change
37.41
Today|||52-Week Range
51.88
-9.05%
Year-to-Date
Sanofi's Risk Increases on Acquisition Miss
1:35pm / GuruFocus News - Paid Partner Content
Cramer: It's a Presidential Campaign, So Let the Corporate Bashing Begin
Aug 24 / TheStreet.com - Paid Partner Content
These Next-Generation Cholesterol Drugs Could Raise U.S. Healthcare Costs by $119 Bil...
Aug 27 / MotleyFool.com - Paid Partner Content
Mylan Falls After Being Called Out on Price Increases -- Should You Worry?
Aug 24 / TheStreet.com - Paid Partner Content
Pharmaceuticals are the New Bonds
Aug 26 / GuruFocus News - Paid Partner Content
Dear Pfizer, Stop Overpaying for Acquisitions!
Aug 24 / MotleyFool.com - Paid Partner Content
Game On for Pfizer With $14 Billion Medivation Buyout (or, Why Pfizer's Buyout of Med...
Aug 26 / MotleyFool.com - Paid Partner Content
Mylan (MYL) Draws Flak for Over Pricing EpiPen, Stock Down
Aug 24 / Zacks.com - Paid Partner Content
Tone-Deaf Mylan Provides Election-Year Fodder
Aug 25 / MotleyFool.com - Paid Partner Content
Regeneron Stock Up on BARDA Deal for MERS Antibodies
Aug 23 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close38.45
Today’s open38.91
Day’s range38.51 - 39.20
Volume2,139,080
Average volume (3 months)2,122,741
Market cap$99.8B
Dividend yield4.29%
Data as of 4:01pm ET, 08/26/2016

Growth & Valuation

Earnings growth (last year)-17.98%
Earnings growth (this year)--
Earnings growth (next 5 years)+4.00%
Revenue growth (last year)-14.57%
P/E ratio24.4
Price/Sales2.96
Price/Book1.58

Competitors

 Today’s
change
Today’s
% change
BMYBristol-Myers Squibb+0.01+0.02%
ABBVAbbVie-0.11-0.17%
AGNAllergan+1.62+0.69%
GSKGlaxoSmithKline-0.19-0.43%
Data as of 4:01pm ET, 08/26/2016

Financials

Next reporting dateOctober 29, 2016
EPS forecast (this quarter)$0.86
Annual revenue (last year)$38.1B
Annual profit (last year)$4.7B
Net profit margin12.77%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Director
Olivier Brandicourt
Chief Financial Officer &
EVP-Finance
Jérôme Contamine
Corporate headquarters
Paris, Ile-de-france

Forecasts

Partner Offers

Search for Jobs